Comprehensive guide to synthetic cannabinoids: from chemistry to toxicity
Synthetic cannabinoids represent the largest class of new psychoactive substances with 190 substances reported to the EU by 2018, acting as more potent full agonists at cannabinoid receptors compared to THC's partial agonism, making them significantly more dangerous.
Quick Facts
What This Study Found
Synthetic cannabinoids are the largest NPS class with 190 substances reported to the EU Early Warning System (2008-2018) and ~280 reported worldwide. Unlike THC (partial agonist), synthetic cannabinoids are full agonists at cannabinoid receptors, making them much more potent. Product composition varies in both substance type and amount. Some may have long half-lives, prolonging psychoactive effects. They have been associated with deaths and acute intoxications across Europe.
Key Numbers
190 substances notified to EU Early Warning System (2008-2018). ~280 reported worldwide to UNODC. Labeled "not for human consumption" to circumvent legislation. Sold as "Spice," "K2," and similar brands.
How They Did This
Comprehensive review covering development history, abuse patterns, legal status, chemical classification, and pharmacological and toxicological properties of synthetic cannabinoids.
Why This Research Matters
Synthetic cannabinoids are widely available, constantly evolving to evade regulation, and significantly more dangerous than natural cannabis. Understanding their properties is essential for harm reduction and clinical response.
The Bigger Picture
The rapid emergence of new synthetic cannabinoid structures outpaces regulatory responses, creating a constantly shifting landscape of uncharacterized substances with unpredictable potency and effects.
What This Study Doesn't Tell Us
Review cannot cover all emerging compounds. Toxicological data for many substances are incomplete. Legal status information rapidly becomes outdated.
Questions This Raises
- ?Can regulatory approaches keep pace with new compound emergence?
- ?Would cannabis legalization reduce synthetic cannabinoid use?
Trust & Context
- Key Stat:
- 190 synthetic cannabinoids reported to the EU by 2018
- Evidence Grade:
- Comprehensive literature review covering multiple aspects of synthetic cannabinoids, synthesizing available pharmacological and toxicological data.
- Study Age:
- 2020 review.
- Original Title:
- The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
- Published In:
- Critical reviews in toxicology, 50(5), 359-382 (2020)
- Database ID:
- RTHC-02380
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why are synthetic cannabinoids more dangerous than cannabis?
Unlike THC which is a partial agonist, synthetic cannabinoids are full agonists at cannabinoid receptors, making them much more potent. They also vary in composition and may have longer half-lives.
How many synthetic cannabinoids exist?
By 2018, 190 substances had been reported to the EU Early Warning System and approximately 280 worldwide, with new compounds constantly emerging to evade regulation.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-purity-potency-label-meaning
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dab-concentrate-addiction-withdrawal
- dating-sober-after-quitting-weed
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- healthiest-way-to-consume-cannabis
- help-someone-quit-weed
- how-cannabis-products-made-concentrates-edibles
- how-to-quit-weed
- journaling-weed-withdrawal
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- sativa-vs-indica-difference-myth
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-potency-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-02380APA
Alves, Vera L; Gonçalves, João L; Aguiar, Joselin; Teixeira, Helena M; Câmara, José S. (2020). The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.. Critical reviews in toxicology, 50(5), 359-382. https://doi.org/10.1080/10408444.2020.1762539
MLA
Alves, Vera L, et al. "The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.." Critical reviews in toxicology, 2020. https://doi.org/10.1080/10408444.2020.1762539
RethinkTHC
RethinkTHC Research Database. "The synthetic cannabinoids phenomenon: from structure to tox..." RTHC-02380. Retrieved from https://rethinkthc.com/research/alves-2020-the-synthetic-cannabinoids-phenomenon
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.